Allogene Therapeutics Inc
NASDAQ:ALLO

Watchlist Manager
Allogene Therapeutics Inc Logo
Allogene Therapeutics Inc
NASDAQ:ALLO
Watchlist
Price: 1.825 USD 0.27%
Market Cap: 382.6m USD

Wall Street
Price Targets

ALLO Price Targets Summary
Allogene Therapeutics Inc

Wall Street analysts forecast ALLO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALLO is 9.223 USD with a low forecast of 3.03 USD and a high forecast of 14.7 USD.

Lowest
Price Target
3.03 USD
66% Upside
Average
Price Target
9.223 USD
405% Upside
Highest
Price Target
14.7 USD
705% Upside

ALLO Last Price Targets
Allogene Therapeutics Inc

The latest public price target was made on May 16, 2024 by Debjit Chattopadhyay from H.C. Wainwright , who expects ALLO stock to rise by 393% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Debjit Chattopadhyay
H.C. Wainwright
9 USD
Upside 393%
8 months ago
May 16, 2024
Allogene (ALLO) PT Lowered to $9 at H.C. Wainwright
StreetInsider
Kalpit Patel
B.Riley Financial
7 USD
Upside 284%
8 months ago
May 14, 2024
Allogene (ALLO) PT Lowered to $7 at B.Riley
StreetInsider
Debjit Chattopadhyay
H.C. Wainwright
Price Target 9 USD
Upside/Downside 393%
View Source
Kalpit Patel
B.Riley Financial
Price Target 7 USD
Upside/Downside 284%
View Source
Allogene Therapeutics Inc Competitors:
Price Targets
QTTB
Homology Medicines Inc
442% Upside
SNDX
Syndax Pharmaceuticals Inc
183% Upside
NIOX
Niox Group PLC
31% Upside
INCY
Incyte Corp
10% Upside
GRAL
Grail Inc
6% Downside
GILD
Gilead Sciences Inc
8% Upside
2160
GNI Group Ltd
26% Upside
300685
Amoy Diagnostics Co Ltd
42% Upside

Revenue
Forecast

Revenue Estimate
Allogene Therapeutics Inc

The compound annual growth rate of Allogene Therapeutics Inc's revenue for the next 4 years is 392%.

N/A
Past Growth
392%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Allogene Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Allogene Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALLO's stock price target?
Price Target
9.223 USD

According to Wall Street analysts, the average 1-year price target for ALLO is 9.223 USD with a low forecast of 3.03 USD and a high forecast of 14.7 USD.

What is Allogene Therapeutics Inc's Revenue forecast?
Projected CAGR
392%

The compound annual growth rate of Allogene Therapeutics Inc's revenue for the next 4 years is 392%.

Back to Top